Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Frontiers in Immunology
|
August 27, 2021
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
Mikel Etxebeste-Mitxeltorena, Inés Del Rincón-Loza, Beatriz Martín-Antonio
Natural Products and Bioprospecting
|
January 11, 2024
Neuroprotective properties of exosomes and chitosan nanoparticles of Tomafran, a bioengineered tomato enriched in crocins
Mikel Etxebeste-Mitxeltorena, Enrique Niza, Cristián Martinez Fajardo, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates
Pablo Garnica, Mikel Etxebeste-Mitxeltorena, Daniel Plano, et al.
Antimicrobial Agents and Chemotherapy
|
October 13, 2020
New Amides Containing Selenium as Potent Leishmanicidal Agents Targeting Trypanothione Reductase
Mikel Etxebeste-Mitxeltorena, Daniel Plano, Socorro Espuelas, et al.
Journal of Medicinal Chemistry
|
April 1, 2020
Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity
Andrea Angeli, Mikel Etxebeste-Mitxeltorena, Carmen Sanmartín, et al.
Antimicrobial Agents and Chemotherapy
|
August 2, 2021
New Phosphoramidates Containing Selenium as Leishmanicidal Agents
Mikel Etxebeste-Mitxeltorena, Daniel Plano, Socorro Espuelas, et al.
Antioxidants (Basel, Switzerland)
|
April 30, 2021
New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
Mikel Etxebeste-Mitxeltorena, Daniel Plano, Nora Astrain-Redín, et al.
Acta Tropica
|
December 22, 2020
3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice
Verónica Alcolea, Esther Moreno, Mikel Etxebeste-Mitxeltorena, et al.
ACS Infectious Diseases
|
April 19, 2021
Selenium Derivatives as Promising Therapy for Chagas Disease: <i>In Vitro</i> and <i>In Vivo</i> Studies
Rubén Martín-Escolano, Mikel Etxebeste-Mitxeltorena, Javier Martín-Escolano, et al.
Bioorganic Chemistry
|
February 12, 2019
Discovery of new organoselenium compounds as antileishmanial agents
Abdul-Malek S Al-Tamimi, Mikel Etxebeste-Mitxeltorena, Carmen Sanmartín, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Frontiers in Immunology
|
August 27, 2021
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
Mikel Etxebeste-Mitxeltorena, Inés Del Rincón-Loza, Beatriz Martín-Antonio
Natural Products and Bioprospecting
|
January 11, 2024
Neuroprotective properties of exosomes and chitosan nanoparticles of Tomafran, a bioengineered tomato enriched in crocins
Mikel Etxebeste-Mitxeltorena, Enrique Niza, Cristián Martinez Fajardo, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates
Pablo Garnica, Mikel Etxebeste-Mitxeltorena, Daniel Plano, et al.
Antimicrobial Agents and Chemotherapy
|
October 13, 2020
New Amides Containing Selenium as Potent Leishmanicidal Agents Targeting Trypanothione Reductase
Mikel Etxebeste-Mitxeltorena, Daniel Plano, Socorro Espuelas, et al.
Journal of Medicinal Chemistry
|
April 1, 2020
Tellurides Bearing Sulfonamides as Novel Inhibitors of Leishmanial Carbonic Anhydrase with Potent Antileishmanial Activity
Andrea Angeli, Mikel Etxebeste-Mitxeltorena, Carmen Sanmartín, et al.
Antimicrobial Agents and Chemotherapy
|
August 2, 2021
New Phosphoramidates Containing Selenium as Leishmanicidal Agents
Mikel Etxebeste-Mitxeltorena, Daniel Plano, Socorro Espuelas, et al.
Antioxidants (Basel, Switzerland)
|
April 30, 2021
New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
Mikel Etxebeste-Mitxeltorena, Daniel Plano, Nora Astrain-Redín, et al.
Acta Tropica
|
December 22, 2020
3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice
Verónica Alcolea, Esther Moreno, Mikel Etxebeste-Mitxeltorena, et al.
ACS Infectious Diseases
|
April 19, 2021
Selenium Derivatives as Promising Therapy for Chagas Disease: <i>In Vitro</i> and <i>In Vivo</i> Studies
Rubén Martín-Escolano, Mikel Etxebeste-Mitxeltorena, Javier Martín-Escolano, et al.
Bioorganic Chemistry
|
February 12, 2019
Discovery of new organoselenium compounds as antileishmanial agents
Abdul-Malek S Al-Tamimi, Mikel Etxebeste-Mitxeltorena, Carmen Sanmartín, et al.
Page
of 2